Quest Diagnostics
815 hedge funds and large institutions have $15.1B invested in Quest Diagnostics in 2021 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 292 increasing their positions, 281 reducing their positions, and 62 closing their positions.
10% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 62
4% more repeat investments, than reductions
Existing positions increased: 292 | Existing positions reduced: 281
1% more capital invested
Capital invested by funds: $15B → $15.1B (+$144M)
0.25% more ownership
Funds ownership: 86.73% → 86.98% (+0.25%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less funds holding
Funds holding: 817 → 815 (-2)
0% less call options, than puts
Call options by funds: $136M | Put options by funds: $137M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$74.3M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$62.2M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$49.6M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$31.5M |
| 5 |
Goldman Sachs
New York
|
+$31.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$129M |
| 2 |
BlackRock
New York
|
-$116M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$96.6M |
| 4 |
Two Sigma Investments
New York
|
-$67.5M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$54.2M |
DGX Hedge Fund Activity: Q2 2021 in Review
815 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2021, worth a combined $15.1B — up 0.96% from $15B a quarter earlier.
Buyers outnumbered sellers: 68 funds opened new DGX positions and 62 closed out — a net gain of 6 holders — while 292 added to existing stakes and 281 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $74.3M. The largest seller was Canada Pension Plan Investment Board, cutting an estimated $129M.
- 815 institutional investors held Quest Diagnostics (DGX) as of Q2 2021, down from 817 in Q1 2021.
- Funds reported $15.1B of Quest Diagnostics stock for Q2 2021, up 0.96% quarter-over-quarter.
- 68 funds opened new Quest Diagnostics positions in Q2 2021 and 62 closed out, a net change of +6 holders.
- The largest Quest Diagnostics buyer in Q2 2021 was Morgan Stanley, an estimated $74.3M added.
- The largest Quest Diagnostics seller in Q2 2021 was Canada Pension Plan Investment Board, an estimated $129M sold.
Based on aggregated 13F filings for Q2 2021.